Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic

  • Aly-Khan A. Lalani
  • Kim N. Chi
  • Daniel Y.C. Heng
  • Christian K. Kollmannsberger
  • Srikala S. Sridhar
  • Normand Blais
  • Christina Canil
  • Piotr Czaykowski
  • Sebastien J. Hotte
  • Nayyer Iqbal
  • Denis Soulières
  • Dominick Bossé
  • Nimira S. Alimohamed
  • Naveen S. Basappa
  • Som D. Mukherjee
  • Eric Winquist
  • Lori A. Wood
  • Scott A. North
Keywords: systemic therapies, genitourinary malignancies, COVID-19, pandemic, Prioritizing
Published
2020-04-05
How to Cite
Lalani, A.-K. A., Chi, K. N., Heng, D. Y., Kollmannsberger, C. K., Sridhar, S. S., Blais, N., Canil, C., Czaykowski, P., Hotte, S. J., Iqbal, N., Soulières, D., Bossé, D., Alimohamed, N. S., Basappa, N. S., Mukherjee, S. D., Winquist, E., Wood, L. A., & North, S. A. (2020). Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic. Canadian Urological Association Journal, 14(5). https://doi.org/10.5489/cuaj.6595
Section
Rapid Communication